Clinical trials do not operate in isolation.
Every protocol ultimately enters a healthcare environment where patients have existing physicians, established treatment plans, work schedules, family responsibilities, insurance requirements, and varying levels of access to specialized care. Research sites balance multiple studies while managing routine clinical responsibilities, and investigators must integrate study procedures into already demanding workflows.
Yet many protocols are still designed with limited visibility into those realities.
This disconnect has long contributed to recruitment delays, protocol amendments, and operational burden. Increasingly, however, sponsors are recognizing that study success depends not only on scientific rigor, but also on how well a protocol aligns with the way healthcare is actually delivered. Across recent industry discussions, a common theme has emerged: designing studies that fit into real-world clinical practice creates stronger foundations for recruitment, site performance, and trial execution.
Clinical Research Begins Long Before the First Patient Is Enrolled
Protocol design is often viewed as the starting point of a clinical trial.
Operationally, however, many of the factors that determine study success already exist before the protocol is finalized. Patient populations are distributed across different care settings. Referral patterns vary by region. Diagnostic pathways differ between academic medical centers and community practices. Some procedures that appear straightforward in theory may require multiple appointments, specialized equipment, or referrals that introduce unexpected delays.
When these realities are not considered early, operational challenges often surface later as recruitment slows, enrollment targets become more difficult to achieve, or sites identify practical concerns that require protocol amendments.
Organizations are increasingly working to understand these factors during study planning rather than discovering them after activation.
Real-World Practice Provides Valuable Design Intelligence
The growing availability of real-world data is helping sponsors evaluate protocol assumptions before studies begin.
Beyond estimating patient populations, these data sources can reveal how diseases are diagnosed, how patients move through healthcare systems, which tests are commonly performed, and where variations in care may affect study feasibility. Combined with operational experience from investigators and research sites, this information provides a more complete picture of how a study is likely to perform in practice.
This broader perspective supports better decision-making throughout protocol development.
Eligibility criteria can be evaluated against actual clinical populations. Visit schedules can be assessed alongside typical standards of care. Procedures that create unnecessary complexity can be identified before they become operational bottlenecks. Rather than relying primarily on historical precedent, study teams have an opportunity to design protocols that reflect the environments in which they will ultimately be executed.
Community Care Is Becoming Part of Clinical Trial Strategy
Many patients receive most of their care outside large academic medical centers.
Community hospitals, regional health systems, and independent physician practices now play an increasingly important role in identifying potential participants and expanding access to research. Designing protocols that fit these environments requires understanding differences in staffing, available technology, referral networks, and day-to-day clinical operations.
This shift has important implications for study planning.
Protocols developed primarily around the capabilities of highly specialized research centers may unintentionally limit participation elsewhere. By considering a wider range of care settings during protocol development, sponsors can expand opportunities for recruitment while creating studies that are more practical for investigators and patients alike.
The result is often a protocol that is not only more inclusive, but also more operationally resilient.
Patient Experience Begins With Study Design
Patient engagement is frequently discussed as something that happens during recruitment.
In reality, much of the participant experience is determined months earlier during protocol development.
Visit frequency, procedure burden, travel requirements, eligibility criteria, and scheduling flexibility all shape whether participation feels manageable. Every additional requirement introduces another consideration that patients must balance against work, caregiving responsibilities, existing medical appointments, and daily life.
Designing studies around these realities does not require compromising scientific objectives.
It requires recognizing that participant experience and operational performance are closely connected. Protocols that reduce unnecessary burden often improve recruitment, strengthen retention, and reduce pressure on research sites responsible for supporting participants throughout the study.
Better Alignment Creates Better Execution
Clinical trial success depends on many factors that remain beyond any organization's control.
Study design, however, remains one of the most influential decisions sponsors make.
Organizations that incorporate real-world clinical practice into protocol development are better positioned to anticipate operational challenges before they become costly delays. They can identify unrealistic assumptions earlier, strengthen site feasibility, improve participant experience, and reduce the need for downstream amendments that disrupt study execution.
This represents an important evolution in how protocols are developed.
Rather than viewing scientific design and operational planning as separate activities, more organizations are beginning to treat them as complementary parts of the same process. Clinical excellence and operational excellence reinforce one another when studies are designed with both objectives in mind.
Designing for the Environment Where Research Actually Happens
Clinical research continues to become more sophisticated, but successful studies are not defined solely by scientific innovation.
They are also defined by how effectively they fit within the healthcare systems responsible for delivering them.
Protocols that reflect real clinical practice, accommodate the needs of patients and research sites, and account for operational realities from the outset create stronger foundations for every stage of trial execution. As sponsors continue searching for ways to improve recruitment, reduce amendments, and accelerate development, designing studies that fit into real healthcare may prove to be one of the most valuable opportunities available.
Continue the Conversation at SCOPE Summit Europe
As clinical research continues to evolve, sponsors are placing greater emphasis on designing studies that are scientifically rigorous, operationally practical, and better aligned with the realities of patient care. From protocol design and feasibility to patient engagement and study execution, these topics will be central to discussions throughout SCOPE Summit Europe.
Join sponsors, CROs, research sites, technology innovators, and clinical operations leaders to explore practical strategies for building more efficient, patient-centered clinical trials.
Learn more and register here.